Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 12—December 2024
EIN Research Letter

Perspectives of Infectious Disease Physicians on Bartonella quintana Cases, United States, 2014–2024

Souci LouisComments to Author , Grace Marx, Alison F. Hinckley, Shannan N. Rich, Susan E. Beekmann, Philip M. Polgreen, Matthew Kuehnert, Jessica N. Ricaldi, and Scott Santibañez
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Louis, G. Marx, A.F. Hinckley, S.N. Rich, M. Kuehnert, J.N. Ricaldi, S. Santibañez); University of Iowa Carver College of Medicine, Iowa City, Iowa, USA (S.E. Beekmann, P.M. Polgreen)

Main Article

Table

Quantitative summary of responses from Emerging Infections Network members across the United States who reported seeing Bartonella quintana infection cases during 2014–2024*

Questions Responses, no. (%)
Question 1. Have you seen any cases?
a. Recently, 2019–2024, n = 240
Yes 44 (18)
No 191 (80)
Not sure
5 (2)
b. More remotely, 2014–2018, n = 240
Yes 34 (14)
No 174 (73)
Not sure 20 (8)
NA (not in practice)
12 (5)
Question 2a. Have you noticed cases within any of the following communities (persons experiencing homelessness, persons with substance use disorder, persons with mental health disorders)? n = 240
Yes 47 (20)
No 17 (7)
Not sure 5 (2)
NA (no cases)
171 (71)
Question 2b. If yes, in which communities? n = 46 [select any that apply; numbers add up to >100%]
Persons experiencing homelessness 42 (91)
Persons with substance use disorders 30 (65)
Persons with mental health disorders
29 (63)
Question 3. What do you see as obstacles(s) to earlier diagnosis for patients with B. quintana infections? n = 203 [select any that apply; numbers add up to >100%]
Lack of clinical suspicion by providers 179 (88)
Lack of provider knowledge about optimal diagnostic tests for B. quintana 148 (73)
Lack of clinically available B. quintana–specific diagnostic tests 103 (51)
No obstacles selected 37 (18)

*Responses were collected from a questionnaire sent to Emerging Infections Network members in 2024 (Appendix). Free-text questions and responses are not shown. NA, not applicable.

Main Article

Page created: November 07, 2024
Page updated: November 26, 2024
Page reviewed: November 26, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external